AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Protara Therapeutics, Inc. Director's Dealing 2025

Mar 28, 2025

34057_dirs_2025-03-28_5738610a-3904-4dc6-9161-72b312296e43.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Protara Therapeutics, Inc. (TARA)
CIK: 0001359931
Period of Report: 2025-01-24

Reporting Person: Zummo Jacqueline (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	120085	Direct

Footnotes

F1: This Form 4 is being filed to amend the previous Form 4 filed on January 28, 2025, which inadvertently misreported the amount of securities beneficially owned by the reporting person following the reported transaction.